SUPN - Supernus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SUPN is currently covered by 4 analysts with an average price target of $61.4. This is a potential upside of $19.48 (46.47%) from yesterday's end of day stock price of $41.92.

Supernus Pharmaceuticals's activity chart (see below) currently has 135 price targets and 105 ratings on display. The stock rating distribution of SUPN is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.93% with an average time for these price targets to be met of 336.63 days.

Highest price target for SUPN is $67, Lowest price target is $55, average price target is $61.4.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 09-Jul-2026. First documented stock forecast 12-Mar-2015.

Currently out of the existing stock ratings of SUPN, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Aug-2025

$67

$25.08 (59.83%)

$63

3 months 23 days ago
(09-Jul-2026)

5/9 (55.56%)

$18.25 (37.44%)

83

Buy Since 02-Jan-2023

$65

$23.08 (55.06%)

$45

7 months 9 days ago
(23-Mar-2026)

2/3 (66.67%)

$15.75 (31.98%)

961

$65

$23.08 (55.06%)

$60

8 months 7 days ago
(25-Feb-2026)

4/6 (66.67%)

$8.68 (15.41%)

258

Hold Since 16-Apr-2020

$55

$13.08 (31.20%)

$50

10 months 13 days ago
(19-Dec-2025)

12/13 (92.31%)

$3.52 (6.84%)

268

Buy Since 17-Oct-2025

$65

$23.08 (55.06%)

$65

1 years 15 days ago
(17-Oct-2025)

26/28 (92.86%)

$14.83 (29.56%)

307

Show more analysts

Please expand the browser size to see the chart

What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?

On average it took 337 days for the stock forecasts to be reached, with an average price target met ratio of 71.93%.

Which analyst most recently updated their price target on SUPN (Supernus Pharmaceuticals)?

Kristen Kluska

Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 4 ratings on SUPN

Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?

John Boris with the highest potential upside of $32.69

Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?

Patrick Trucchio with the lowest potential downside of -$17.92
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?